BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16554735)

  • 21. Expression of CD34 and bcl-2 in phyllodes tumours, fibroadenomas and spindle cell lesions of the breast.
    Moore T; Lee AH
    Histopathology; 2001 Jan; 38(1):62-7. PubMed ID: 11135048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic landscapes of breast fibroepithelial tumors.
    Tan J; Ong CK; Lim WK; Ng CC; Thike AA; Ng LM; Rajasegaran V; Myint SS; Nagarajan S; Thangaraju S; Dey S; Nasir ND; Wijaya GC; Lim JQ; Huang D; Li Z; Wong BH; Chan JY; McPherson JR; Cutcutache I; Poore G; Tay ST; Tan WJ; Putti TC; Ahmad BS; Iau P; Chan CW; Tang AP; Yong WS; Madhukumar P; Ho GH; Tan VK; Wong CY; Hartman M; Ong KW; Tan BK; Rozen SG; Tan P; Tan PH; Teh BT
    Nat Genet; 2015 Nov; 47(11):1341-5. PubMed ID: 26437033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of imprinting of IGF2 in fibroadenomas and phyllodes tumors of the breast.
    Mishima C; Kagara N; Tanei T; Naoi Y; Shimoda M; Shimomura A; Shimazu K; Kim SJ; Noguchi S
    Oncol Rep; 2016 Mar; 35(3):1511-8. PubMed ID: 26676988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the progression of fibroepithelial tumours of the breast by PCR-based clonality assay.
    Kuijper A; Buerger H; Simon R; Schaefer KL; Croonen A; Boecker W; van der Wall E; van Diest PJ
    J Pathol; 2002 Aug; 197(5):575-81. PubMed ID: 12210075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormone receptors expression in phyllodes tumors of the breast.
    Kim YH; Kim GE; Lee JS; Lee JH; Nam JH; Choi C; Park MH; Yoon JH
    Anal Quant Cytol Histol; 2012 Feb; 34(1):41-8. PubMed ID: 22590818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytological Criteria to Distinguish Phyllodes Tumour of the Breast from Fibroadenoma.
    Maritz RM; Michelow PM
    Acta Cytol; 2017; 61(6):418-424. PubMed ID: 28738381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential cytologic features of fibroepithelial lesions of the breast.
    Deen SA; McKee GT; Kissin MW
    Diagn Cytopathol; 1999 Feb; 20(2):53-6. PubMed ID: 9951596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A subset of malignant phyllodes tumors harbors alterations in the Rb/p16 pathway.
    Cimino-Mathews A; Hicks JL; Sharma R; Vang R; Illei PB; De Marzo A; Emens LA; Argani P
    Hum Pathol; 2013 Nov; 44(11):2494-500. PubMed ID: 23916291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-catenin abnormalities and associated insulin-like growth factor overexpression are important in phyllodes tumours and fibroadenomas of the breast.
    Sawyer EJ; Hanby AM; Poulsom R; Jeffery R; Gillett CE; Ellis IO; Ellis P; Tomlinson IP
    J Pathol; 2003 Aug; 200(5):627-32. PubMed ID: 12898599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD10+ stromal cells in fibroadenomas and phyllodes tumors of the breast.
    Zamecnik M; Kinkor Z; Chlumska A
    Virchows Arch; 2006 Jun; 448(6):871-2. PubMed ID: 16550395
    [No Abstract]   [Full Text] [Related]  

  • 31. Fibroepithelial tumours of the breast-a review.
    Lerwill MF; Lee AHS; Tan PH
    Virchows Arch; 2022 Jan; 480(1):45-63. PubMed ID: 34505197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proliferating activity in the epithelial and stromal component of fibroadenomas and phyllodes tumours of the breast.
    Barwijuk-Machała M; Reszeć J; Baltaziak M; Musiatowicz B; Cylwik J
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():55-7. PubMed ID: 15638374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in the Diagnosis of Phyllodes Tumors and Fibroadenomas Before and After Release of WHO Classification Standards.
    Chang J; Denham L; Dong EK; Malek K; Lum SS
    Ann Surg Oncol; 2018 Oct; 25(10):3088-3095. PubMed ID: 29987607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Most cystosarcoma phyllodes and fibroadenomas have progesterone receptor but lack estrogen receptor: stromal localization of progesterone receptor.
    Rao BR; Meyer JS; Fry CG
    Cancer; 1981 Apr; 47(8):2016-21. PubMed ID: 6261932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical study of MIB1 expression in phyllodes tumor and fibroadenoma.
    Umekita Y; Yoshida H
    Pathol Int; 1999 Sep; 49(9):807-10. PubMed ID: 10504552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benign phyllodes tumour vs fibroadenoma: FNA cytological differentiation.
    Veneti S; Manek S
    Cytopathology; 2001 Oct; 12(5):321-8. PubMed ID: 11722512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Precise diagnosis of breast phyllodes tumors using Raman spectroscopy: Biochemical fingerprint, tumor metabolism and possible mechanism.
    Wu Y; Wang Y; He C; Wang Y; Ma J; Lin Y; Zhou L; Xu S; Ye Y; Yin W; Ye J; Lu J
    Anal Chim Acta; 2023 Dec; 1283():341897. PubMed ID: 37977771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proliferative activity and tumor angiogenesis is closely correlated to stromal cellularity of fibroadenoma: proposal fibroadenoma, cellular variant.
    Hasebe T; Imoto S; Sasaki S; Tsubono Y; Mukai K
    Pathol Int; 1999 May; 49(5):435-43. PubMed ID: 10417687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sonographic features of phyllodes tumors of the breast.
    Chao TC; Lo YF; Chen SC; Chen MF
    Ultrasound Obstet Gynecol; 2002 Jul; 20(1):64-71. PubMed ID: 12100421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Diagnostic Approach to Fibroepithelial Breast Lesions.
    Tan BY; Tan PH
    Surg Pathol Clin; 2018 Mar; 11(1):17-42. PubMed ID: 29413655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.